cro.directory
← Compare landing

iXCells Biotechnologies vs Scantox

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryiXCells BiotechnologiesScantox
SummaryOffers iPSC reprogramming, CRISPR genome editing, directed differentiation, and in vitro bioassay and ASO screening services. Builds human iPSC-derived cellular models for preclinical drug discovery.Preclinical CRO with a CNS/neurology focus, offering in vivo transgenic and induced disease models for Alzheimer's, Parkinson's, ALS, and Huntington's alongside in vitro assays for tau and α-synuclein aggregation, neuroinflammation, and neuronal plasticity.
Services
  • Discovery Research
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Discovery Research
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Specialized & Large-Animal Models
  • Pathology & Histology Services
Modalities
  • Oligonucleotide
Data not yet provided.
Indications
  • Neurology
  • Neurology
  • Psychiatry
Phases
  • Discovery
  • Preclinical (General)
  • Discovery
  • Preclinical (General)
Sourcing modelsData not yet provided.Data not yet provided.
LocationsData not yet provided.Data not yet provided.
CertificationsData not yet provided.Data not yet provided.

Find similar companies

iXCells Biotechnologies alternatives · Scantox alternatives

Markdown mirror: /compare/ixcells-biotechnology/scantox.md